The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis.
about
Standards and impact of hematopathology in myelodysplastic syndromes (MDS).Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera.Highlights of 2008 in bone marrow biopsy pathology.Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms.Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
P2860
The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The implication of identifying ...... mes with bone marrow fibrosis.
@en
type
label
The implication of identifying ...... mes with bone marrow fibrosis.
@en
prefLabel
The implication of identifying ...... mes with bone marrow fibrosis.
@en
P2093
P2860
P1476
The implication of identifying ...... mes with bone marrow fibrosis.
@en
P2093
April A Ewton
Cherie H Dunphy
Chung-Che Chang
Dennis P O'Malley
Lawrence Rice
Randall J Olsen
P2860
P2888
P304
P356
10.1007/S12308-008-0014-8
P577
2008-08-28T00:00:00Z
P5875
P6179
1027032848